环肽大环化合物和环缩肽的渗透性及其作为治疗药物的潜力。
Permeability of Cyclic Peptide Macrocycles and Cyclotides and Their Potential as Therapeutics.
作者信息
Liras Spiros, Mcclure Kim F
机构信息
Biogen Inc., 225 Binney Street, Cambridge, Massachusetts 02142, United States.
Pinteon Therapeutics, 1188 Centre Street, Newton Centre, Massachusetts 02549, United States.
出版信息
ACS Med Chem Lett. 2019 Jun 14;10(7):1026-1032. doi: 10.1021/acsmedchemlett.9b00149. eCollection 2019 Jul 11.
Abstract
Macrocycles have emerged as a viable approach for the modulation of tough targets in drug discovery. In this Innovations article we discuss recent progress toward the design of cell permeable and orally bioavailable peptide macrocycles and cyclotides and provide a perspective for their potential as therapeutics. We highlight design concepts that may be broadly relevant to drug discovery efforts beyond the rule of five.
摘要
大环化合物已成为药物研发中调控棘手靶点的一种可行方法。在这篇创新文章中，我们讨论了在设计可穿透细胞且口服生物利用的肽大环化合物和环肽方面的最新进展，并展望了它们作为治疗药物的潜力。我们强调了一些设计理念，这些理念可能广泛适用于超出“五规则”的药物研发工作。
相似文献
1
Permeability of Cyclic Peptide Macrocycles and Cyclotides and Their Potential as Therapeutics.环肽大环化合物和环缩肽的渗透性及其作为治疗药物的潜力。
ACS Med Chem Lett. 2019 Jun 14;10(7):1026-1032. doi: 10.1021/acsmedchemlett.9b00149. eCollection 2019 Jul 11.
2
The Potential of the Cyclotide Scaffold for Drug Development.环肽支架在药物开发中的潜力。
Biomedicines. 2019 Apr 19;7(2):31. doi: 10.3390/biomedicines7020031.
3
Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?大环药物和临床候选药物：药物化学家可以从它们的性质中学到什么？
J Med Chem. 2014 Jan 23;57(2):278-95. doi: 10.1021/jm400887j. Epub 2013 Sep 17.
4
Cell permeability beyond the rule of 5.超过 5 规则的细胞通透性。
Adv Drug Deliv Rev. 2016 Jun 1;101:42-61. doi: 10.1016/j.addr.2016.03.013. Epub 2016 Apr 9.
5
Recent progress towards pharmaceutical applications of disulfide-rich cyclic peptides.富含二硫键的环肽在药物应用方面的最新进展。
Curr Protein Pept Sci. 2013 Sep;14(6):532-42. doi: 10.2174/13892037113149990069.
6
Discovery and optimization of peptide macrocycles.多肽大环的发现和优化。
Expert Opin Drug Discov. 2016 Dec;11(12):1151-1163. doi: 10.1080/17460441.2016.1245720. Epub 2016 Oct 16.
7
Oxadiazole grafts in peptide macrocycles.恶二唑在肽大环中的接枝。
Nat Chem. 2016 Dec;8(12):1105-1111. doi: 10.1038/nchem.2636. Epub 2016 Oct 24.
8
Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides.口服生物可利用的环状六肽的灵活性与刚性
Chembiochem. 2015 Nov 2;16(16):2289-93. doi: 10.1002/cbic.201500441. Epub 2015 Oct 7.
9
Pharmaceutical applications of cyclotides.环肽的药物应用。
Drug Discov Today. 2019 Nov;24(11):2152-2161. doi: 10.1016/j.drudis.2019.09.010. Epub 2019 Sep 18.
10
Cyclotides as a basis for drug design.环肽作为药物设计的基础。
Expert Opin Drug Discov. 2012 Mar;7(3):179-94. doi: 10.1517/17460441.2012.661554. Epub 2012 Feb 21.
引用本文的文献
1
Systematic Determination of the Impact of Structural Edits on Peptide Accumulation into Mycobacteria.系统测定结构编辑对肽在分枝杆菌中积累的影响
ACS Chem Biol. 2025 Aug 15;20(8):1962-1979. doi: 10.1021/acschembio.5c00330. Epub 2025 Aug 1.
2
A Sydnonimine-based Click-and-Release Approach to Cyclic Products.一种基于 sydnonimine 的环化产物点击释放方法。
Chemistry. 2025 May 27;31(30):e202500860. doi: 10.1002/chem.202500860. Epub 2025 Apr 21.
3
Cyclic Peptide C5aR1 Antagonist Design Using Solution Conformational Analysis Derived from Residual Dipolar Couplings.基于剩余偶极耦合推导的溶液构象分析设计环肽C5aR1拮抗剂
ACS Med Chem Lett. 2024 Oct 29;15(11):2060-2066. doi: 10.1021/acsmedchemlett.4c00316. eCollection 2024 Nov 14.
4
Flexible fluorine-thiol displacement stapled peptides with enhanced membrane penetration for the estrogen receptor/coactivator interaction.具有增强膜穿透能力的柔性氟硫醇置换型订书肽，用于雌激素受体/共激活因子相互作用
J Biol Chem. 2024 Dec;300(12):107991. doi: 10.1016/j.jbc.2024.107991. Epub 2024 Nov 13.
5
Multi-site esterification: a tunable, reversible strategy to tailor therapeutic peptides for delivery.多位点酯化：一种用于定制治疗性肽以实现递送的可调节、可逆策略。
Mol Syst Des Eng. 2024 Sep 13;9(12):1215-1227. doi: 10.1039/d4me00072b. eCollection 2024 Nov 26.
6
Rational design of small-sized peptidomimetic inhibitors disrupting protein-protein interaction.破坏蛋白质-蛋白质相互作用的小型拟肽抑制剂的合理设计。
RSC Med Chem. 2024 May 7;15(7):2212-2225. doi: 10.1039/d4md00202d. eCollection 2024 Jul 17.
7
An amide to thioamide substitution improves the permeability and bioavailability of macrocyclic peptides.酰胺到硫代酰胺的取代可提高大环肽的通透性和生物利用度。
Nat Commun. 2023 Sep 28;14(1):6050. doi: 10.1038/s41467-023-41748-y.
8
Hydrogel-Encapsulated Beads Enable Proximity-Driven Encoded Library Synthesis and Screening.水凝胶包裹的微珠实现邻近驱动的编码文库合成与筛选。
ACS Cent Sci. 2023 Jul 13;9(8):1603-1610. doi: 10.1021/acscentsci.3c00316. eCollection 2023 Aug 23.
9
A Review: The Antiviral Activity of Cyclic Peptides.综述：环肽的抗病毒活性
Int J Pept Res Ther. 2023;29(1):7. doi: 10.1007/s10989-022-10478-y. Epub 2022 Dec 1.
10
Harnessing the Therapeutic Potential of Biomacromolecules through Intracellular Delivery of Nucleic Acids, Peptides, and Proteins.通过将核酸、肽和蛋白质递送至细胞内来挖掘生物大分子的治疗潜力。
Adv Healthc Mater. 2022 Jun;11(12):e2102600. doi: 10.1002/adhm.202102600. Epub 2022 Mar 23.
本文引用的文献
1
Toward the elucidation of the mechanism for passive membrane permeability of cyclic peptides.旨在阐明环肽被动膜通透性的机制。
Future Med Chem. 2019 Apr;11(7):637-639. doi: 10.4155/fmc-2018-0429. Epub 2019 Mar 28.
2
Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges.作为药物候选物的大环肽：最新进展和尚存的挑战。
J Am Chem Soc. 2019 Mar 13;141(10):4167-4181. doi: 10.1021/jacs.8b13178. Epub 2019 Feb 27.
3
Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry.分子内氢键：改善药物化学设计的机会。
Med Res Rev. 2019 Sep;39(5):1707-1729. doi: 10.1002/med.21562. Epub 2019 Jan 19.
4
Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility.亲脂性渗透率效率调和了亲脂性在膜通透性和水溶解度方面的相反作用。
J Med Chem. 2018 Dec 27;61(24):11169-11182. doi: 10.1021/acs.jmedchem.8b01259. Epub 2018 Dec 11.
5
Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs.五规则影响下的二十年和已批准口服药物性质的变化。
J Med Chem. 2019 Feb 28;62(4):1701-1714. doi: 10.1021/acs.jmedchem.8b00686. Epub 2018 Sep 27.
6
Orally Active Peptides: Is There a Magic Bullet?口服活性肽：是否存在灵丹妙药？
Angew Chem Int Ed Engl. 2018 Oct 26;57(44):14414-14438. doi: 10.1002/anie.201807298. Epub 2018 Oct 3.
7
Interfering peptides targeting protein-protein interactions: the next generation of drugs?靶向蛋白-蛋白相互作用的干扰肽：下一代药物？
Drug Discov Today. 2018 Feb;23(2):272-285. doi: 10.1016/j.drudis.2017.10.016. Epub 2017 Oct 31.
8
Overcoming the Lack of Oral Availability of Cyclic Hexapeptides: Design of a Selective and Orally Available Ligand for the Integrin αvβ3.克服环状六肽口服生物利用度低的问题：设计一种选择性和口服有效的整合素 αvβ3 配体。
Angew Chem Int Ed Engl. 2017 Dec 18;56(51):16405-16409. doi: 10.1002/anie.201709709. Epub 2017 Nov 23.
9
Discovery of Potent and Orally Bioavailable Macrocyclic Peptide-Peptoid Hybrid CXCR7 Modulators.强效且口服生物可利用的大环肽-类肽杂合CXCR7调节剂的发现。
J Med Chem. 2017 Dec 14;60(23):9653-9663. doi: 10.1021/acs.jmedchem.7b01028. Epub 2017 Oct 30.
10
Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection.超越 5 规则：艾伯维药物和化合物收藏的经验教训。
J Med Chem. 2018 Apr 12;61(7):2636-2651. doi: 10.1021/acs.jmedchem.7b00717. Epub 2017 Sep 27.
Zotero 插件